Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm.

Dosage regimens should generally be individualised, depending on features of the patient that can alter the drug's pharmacokinetics (disposition in the body) or pharmacodynamics (therapeutic and adverse effects). It is usually good practice to start with a low dose, gradually increasing it acco...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Aronson, J
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2005

Eitemau Tebyg

Assessing perceptions of benefit and harm of common drug therapies using therapeutic scenarios
gan: Aronson, J, et al.
Cyhoeddwyd: (2003)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
gan: Aronson, J
Cyhoeddwyd: (2016)

Balancing benefits and harms in health care.
gan: Cuervo, L, et al.
Cyhoeddwyd: (2003)

Lorcaserin in obesity: minimal benefits and ill-defined harms
gan: Onakpoya, I, et al.
Cyhoeddwyd: (2019)

Sun Exposure in Children: Balancing the Benefits and Harms
gan: Ankur K Jindal, et al.
Cyhoeddwyd: (2020-01-01)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
gan: E. N. Bochanova
Cyhoeddwyd: (2015-09-01)

ON THE SELECTION OF DRUGS DOSAGE REGIMEN
gan: E. N. Bochanova
Cyhoeddwyd: (2015-09-01)

Patentability of Pharmaceutical Dosage Regimens in Europe
gan: Mahdi Zahedi, et al.
Cyhoeddwyd: (2013-03-01)

Increasing Risks to the Health of the Invertebrates—Balancing between Harm and Benefit
gan: Tatiana V. Kuznetsova, et al.
Cyhoeddwyd: (2024-05-01)

ChatGPT and mental healthcare: balancing benefits with risks of harms
gan: John Torous, et al.
Cyhoeddwyd: (2023-10-01)

Application of Monte Carlo simulation to optimise the dosage regimen of meropenem in patients with augmented renal clearance for Pseudomonas aeruginosa infection
gan: Jia Hou, et al.
Cyhoeddwyd: (2024-06-01)

Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment
gan: Bruce Leff, et al.
Cyhoeddwyd: (2019-08-01)

Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis.
gan: Ferner, R, et al.
Cyhoeddwyd: (2013)

The appropriate use of human albumin in a Brazilian University Hospital: therapeutic indication and dosage regimen
gan: Tatiane Sayuri Ishida, et al.
Cyhoeddwyd: (2019-04-01)

Contraceptive and therapeutic effects of drospirenone-containing hormonal antifertility agent with 24/4 dosage regimen
gan: M A Gevorkian, et al.
Cyhoeddwyd: (2013-06-01)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
gan: Cipriani, A, et al.
Cyhoeddwyd: (2005)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
gan: Xiangqing Song, et al.
Cyhoeddwyd: (2022-06-01)

Monitoring for harms of therapy.
gan: Aronson, J
Cyhoeddwyd: (2006)

Selective digestive decontamination, a seemingly effective regimen with individual benefit or a flawed concept with population harm?
gan: James C. Hurley
Cyhoeddwyd: (2021-09-01)

Individualized antibiotic dosage regimens for patients with augmented renal clearance
gan: A-Xi Shi, et al.
Cyhoeddwyd: (2023-07-01)

Optimizing vancomycin dosage regimen at the University Medical Center Maribor
gan: Maja Cvikl, et al.
Cyhoeddwyd: (2011-12-01)

DISPOSITION KINETICS AND DOSAGE REGIMEN OF INTRAVENOUSLY INJECTED KANAMYCIN IN BUFFALOES
gan: T. Saeed, R. Ahmad, M. Nawaz1 and T. Iqbal
Cyhoeddwyd: (2000-01-01)

Dosage regimen and toxicity risk assessment of linezolid in sepsis patients
gan: Linjie Dou, et al.
Cyhoeddwyd: (2020-07-01)

Exposure to benzylpenicillin after different dosage regimens in growing pigs
gan: Marie Sjölund, et al.
Cyhoeddwyd: (2020-09-01)

Dosage adjustment in renal insufficiency: comparison between databases
gan: Isabella Faria MARANHÃO, et al.
Cyhoeddwyd: (2024-03-01)

Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage
gan: M. de Jong, et al.
Cyhoeddwyd: (2023-12-01)

Adverse drug reactions--no farewell to harms.
gan: Aronson, J
Cyhoeddwyd: (2007)

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
gan: Myriam Briki, et al.
Cyhoeddwyd: (2023-04-01)

Market harms and market benefits
gan: Wilkinson, H
Cyhoeddwyd: (2022)

Balance between solitude and socializing: everyday solitude time both benefits and harms well-being
gan: Netta Weinstein, et al.
Cyhoeddwyd: (2023-12-01)

Scheduled dosage regimen by irreversible electroporation of loaded erythrocytes for cancer treatment
gan: Wencheng Peng, et al.
Cyhoeddwyd: (2023-12-01)

Population Pharmacokinetic Modeling of Zaltoprofen in Healthy Adults: Exploring the Dosage Regimen
gan: Ji-Hun Jang, et al.
Cyhoeddwyd: (2023-01-01)

Chloroquine dosage regimen simulation for pediatric patients with coronavirus disease 2019
gan: Kiatkriangkrai Koyratkoson, et al.
Cyhoeddwyd: (2022-07-01)

Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages.
gan: Ayari Fuentes-Hernandez, et al.
Cyhoeddwyd: (2015-04-01)

Short-Term Dosage Regimen for Stimulation-Induced Long-Lasting Desynchronization
gan: Thanos Manos, et al.
Cyhoeddwyd: (2018-04-01)

Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions
gan: Mauro Alaibac
Cyhoeddwyd: (2018-04-01)

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
gan: Onakpoya, I, et al.
Cyhoeddwyd: (2018)

Optimising dosage of Lytag used as coarse aggregate in lightweight aggregate concretes
gan: S Ahmad, et al.
Cyhoeddwyd: (2013-04-01)

Tylosin Dosage Adjustment Based on Allometric Scaling in Male Turkeys
gan: Błażej Poźniak, et al.
Cyhoeddwyd: (2021-08-01)

Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen
gan: Natasha Strydom, et al.
Cyhoeddwyd: (2024-08-01)